48 related articles for article (PubMed ID: 15126797)
1. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
Greene KL; Meng MV; Elkin EP; Cooperberg MR; Pasta DJ; Kattan MW; Wallace K; Carroll PR
J Urol; 2004 Jun; 171(6 Pt 1):2255-9. PubMed ID: 15126797
[TBL] [Abstract][Full Text] [Related]
2. Five-year effectiveness of low-dose-rate brachytherapy: comparisons with nomogram predictions in patients with non-metastatic prostate cancer presenting significant control of intra- and periprostatic disease.
Zimmermann JS; Osieka R; Bruns T; Hollberg H; Wiechmann B; Netzbandt O; Sablotny J; Malade M; Heitz M; Bernhardt F; Tiemann J; Wilkens M; Brüske T; Welker U; Heinemann V; Zimmermann P; de la Maza SF; Pfeiffer D; Tauber PR; Thomas D; Moustakis C
J Contemp Brachytherapy; 2018 Aug; 10(4):297-305. PubMed ID: 30237813
[TBL] [Abstract][Full Text] [Related]
3. Updated trends in imaging use in men diagnosed with prostate cancer.
Porten SP; Smith A; Odisho AY; Litwin MS; Saigal CS; Carroll PR; Cooperberg MR;
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):246-51. PubMed ID: 24819235
[TBL] [Abstract][Full Text] [Related]
4. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
5. Robust genomic copy number predictor of pan cancer metastasis.
Pearlman A; Upadhyay K; Cole K; Loke J; Sun K; Fineberg S; Freedland SJ; Shao Y; Ostrer H
Genes Cancer; 2018 Jan; 9(1-2):66-77. PubMed ID: 29725504
[TBL] [Abstract][Full Text] [Related]
6. The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements.
Gaudreau PO; Stagg J; Soulières D; Saad F
Biomark Cancer; 2016; 8(Suppl 2):15-33. PubMed ID: 27168728
[TBL] [Abstract][Full Text] [Related]
7. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ
J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059
[TBL] [Abstract][Full Text] [Related]
8. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
Su YJ; Yu J; Huang YQ; Yang J
Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
[TBL] [Abstract][Full Text] [Related]
9. Improving prediction of prostate cancer recurrence using chemical imaging.
Kwak JT; Kajdacsy-Balla A; Macias V; Walsh M; Sinha S; Bhargava R
Sci Rep; 2015 Mar; 5():8758. PubMed ID: 25737022
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the cancer of the prostate risk assessment score for recurrence-free survival after radical prostatectomy in Korea: a single-surgeon series.
Seo WI; Kang PM; Chung JI
Korean J Urol; 2014 May; 55(5):321-6. PubMed ID: 24868336
[TBL] [Abstract][Full Text] [Related]
11. Circulating nucleic acids as biomarkers of prostate cancer.
Sita-Lumsden A; Fletcher CE; Dart DA; Brooke GN; Waxman J; Bevan CL
Biomark Med; 2013 Dec; 7(6):867-77. PubMed ID: 24266819
[TBL] [Abstract][Full Text] [Related]
12. Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.
Glass AS; Punnen S; Cooperberg MR
Korean J Urol; 2013 Jul; 54(7):417-25. PubMed ID: 23878682
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as potential new biomarkers for prostate cancer.
Sita-Lumsden A; Dart DA; Waxman J; Bevan CL
Br J Cancer; 2013 May; 108(10):1925-30. PubMed ID: 23632485
[TBL] [Abstract][Full Text] [Related]
14. Are preoperative Kattan and Stephenson nomograms predicting biochemical recurrence after radical prostatectomy applicable in the Chinese population?
Yeung VH; Chiu Y; Yu SS; Au WH; Chan SW
ScientificWorldJournal; 2013; 2013():506062. PubMed ID: 23533351
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a 32-gene prognostic index for prostate cancer progression.
Wu CL; Schroeder BE; Ma XJ; Cutie CJ; Wu S; Salunga R; Zhang Y; Kattan MW; Schnabel CA; Erlander MG; McDougal WS
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6121-6. PubMed ID: 23533275
[TBL] [Abstract][Full Text] [Related]
16. The UREThRAL stricture score: A novel method for describing anterior urethral strictures.
Wiegand LR; Brandes SB
Can Urol Assoc J; 2012 Aug; 6(4):260-4. PubMed ID: 23093535
[TBL] [Abstract][Full Text] [Related]
17. Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer.
Piñero A; Canteras M; Moreno A; Vicente F; Giménez J; Tocino A; Iglesias E; Vidal-Sicart S; Santamaría L; Lorenzo M; García M; Ramirez D;
Clin Transl Oncol; 2013 Feb; 15(2):117-23. PubMed ID: 22855171
[TBL] [Abstract][Full Text] [Related]
18. The association between tumour density and prostate cancer recurrence following radical prostatectomy.
Lavallée LT; Breau RH; Preston MA; Raju G; Morash C; Doucette S; Gerridzen RG; Eastham J; Cagiannos I
Can Urol Assoc J; 2011 Dec; 5(6):397-401. PubMed ID: 22154633
[TBL] [Abstract][Full Text] [Related]
19. Prediction models in cancer care.
Vickers AJ
CA Cancer J Clin; 2011; 61(5):315-26. PubMed ID: 21732332
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
